publicações selecionadas
-
artigo de revista
- New Ruthenium-Cyclopentadienyl Complexes Affect Colorectal Cancer Hallmarks Showing High Therapeutic Potential. Pharmaceutics. 2023
- Polymer “ruthenium-cyclopentadienyl” conjugates - New emerging anti-cancer drugs. European Journal of Medicinal Chemistry. 2019
- Bacteriophage biodistribution and infectivity from honeybee to bee larvae using a T7 phage model. Acta Cytologica. 2019
-
capítulo de livro
-
documento
- New ruthenium-cyclopentadienyl agents as a new strategy to fight colorectal cancer 2021
- Ruthenium-based agents as promising metallodrugs to fight colorectal cancer 2020
- Fighting colorectal cancer with ruthenium-based agents 2020
- New ruthenium-based agents target actin cytoskeleton in colorectal cancer cells 2020
- New ruthenium-biotinylated anticancer agents for colorectal cancer therapy 2019
- Discovering the molecular targets of new ruthenium-based anticancer agents for colorectal cancer therapy 2019
- New ruthenium-based anticancer agents: uncovering the molecular targets towards colorectal cancer therapy 2019
- Bacteriophage biodistribution and infectivity from honeybee to bee larvae 2018
- Bacteriophages as a natural and novel tool to control American Foulbrood 2018
- Mitochondrial ROS accumulation sensitizes colorectal cancer cells to acetate and Cathepsin D inhibitors combination therapy 2017
- Isolation and characterization of bacteriophages infecting Paenibacillus larvae 2012